✦ LIBER ✦

Erratum to: Bone-Targeted Therapies for Elderly Patients with Renal Cell Carcinoma: Current and Future Directions

✍ Scribed by Roza, Thomas; Hakim, Lukman; Poppel, Hendrik; Joniau, Steven

Book ID: 121582661
Publisher: Springer International Publishing AG
Year: 2013
Tongue: English
Weight: 136 KB
Volume: 31
Category: Article
ISSN: 1170-229X
DOI: 10.1007/s40266-013-0139-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bone-Targeted Therapies for Elderly Pati

Bone-Targeted Therapies for Elderly Patients with Renal Cell Carcinoma: Current and Future Directions

✍ Roza, Thomas; Hakim, Lukman; Poppel, Hendrik; Joniau, Steven 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 278 KB

Integrating Surgery with Targeted Therap

Integrating Surgery with Targeted Therapies for Renal Cell Carcinoma: Current Evidence and Ongoing Trials

✍ Axel Bex; Eric Jonasch; Ziya Kirkali; Arnaud Mejean; Peter Mulders; Stephane Oud 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 423 KB

Pilot Trial of Bone-Targeted Therapy Com

Pilot Trial of Bone-Targeted Therapy Combining Zoledronate With Fluvastatin or Atorvastatin for Patients With Metastatic Renal Cell Carcinoma

✍ George E. Manoukian; Nizar M. Tannir; Eric Jonasch; Wei Qiao; Tamara M. Haygood; 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 562 KB

Economic evaluation of new targeted ther

Economic evaluation of new targeted therapies for the first-line treatment of patients with metastatic renal cell carcinoma

✍ Ágnes Benedict; Robert A. Figlin; Per Sandström; Ulrika Harmenberg; Anders Ullén 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 378 KB

Pilot trial of bone-targeted therapy wit

Pilot trial of bone-targeted therapy with zoledronate, thalidomide, and interferon-γ for metastatic renal cell carcinoma

✍ Nizar Tannir; Eric Jonasch; Lance C. Pagliaro; Paul Mathew; Arlene Siefker-Radtk 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 482 KB 👁 1 views

## Abstract ## BACKGROUND. The purpose of the study was to evaluate the efficacy and safety of a bone‐targeted regimen consisting of zoledronate, thalidomide, and interferon‐γ in patients with renal cell carcinoma and bone metastases. ## METHODS. Eligible patients had radiographic evidence of bo

SURGICAL MORBIDITY ASSOCIATED WITH ADMIN

SURGICAL MORBIDITY ASSOCIATED WITH ADMINISTRATION OF TARGETED MOLECULAR THERAPIES PRIOR TO CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA

✍ Margulis, Vitaly; Matin, Surena F; Tamboli, Pheroze; Swanson, David A; Wood, Chr 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 156 KB